In a murine tumor model, the administration of this engineered bacterial strain changed the tumor microenvironment by elevating IFN‐γ and CXCL9 levels, increasing T‐cell infiltration, and enhancing immune activation in the murine tumor model. This evidence concerns the gene IFNG and neoplasm.